Colitis ulcerosa: vizsgálatok itt: Spanyolország
26 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleAn Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
- Where
- Barcelona, Córdoba, Huelva, Las Palmas De Gran Canaria, Madrid, Santiago de Compostela, Sevilla, Tomelloso, Valencia
- Életkor
- 18 év and over
- People
- 593 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2023-507853-13-00 · EU 2023-507853-13-00 - 2. fázisCsak meghívásosLong-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
- Where
- Gijón, Lugo, Madrid, Majadahonda, Ourense, Santiago de Compostela, Sevilla
- Életkor
- 18 év and over
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00 - 3. fázisTaking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia
- Életkor
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - 2. fázisTaking peopleLY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Where
- Barcelona, Fuenlabrada, Gijón, Madrid
- Életkor
- 18 év to 80 év
- People
- 252 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07186101 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Santiago de Compostela, Valencia
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - 3. fázisTaking peopleA Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Alicante, Madrid, Santiago de Compostela, Sevilla, Vigo, Zaragoza
- Életkor
- 18 év and over
- People
- 644 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00 - No phaseNot yet taking people in SpanyolországA Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis
- Where
- Santiago de Compostela
- Életkor
- 18 év and over
- People
- 200
- Run by
- Janssen-Cilag, S.A.
See details and how to joinNCT07848737 - 4. fázisTaking peopleA study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indication
- Where
- Madrid
- People
- 16 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2025-522362-78-00 · EU 2025-522362-78-00 - 1/2. fázisTaking peopleStudy of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Where
- Barcelona, Valencia
- Életkor
- 18 év to 75 év
- People
- 270 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT06619990 - 2. fázisTaking peopleA Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Where
- Barcelona, Córdoba, Sabadell, Santiago de Compostela
- Életkor
- 12 év to 17 év
- People
- 36 worldwide
- Run by
- Pfizer
See details and how to joinNCT05287126 · EU 2022-500345-25-00 - 2. fázisTaking peopleA Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Gijón, Lugo, Madrid, Majadahonda, Ourense, Santiago de Compostela, Sevilla
- Életkor
- 18 év to 75 év
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00 - 3. fázisTaking peopleA Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Where
- A Coruña, Majadahonda
- Életkor
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- AbbVie
See details and how to joinNCT07071519 · EU 2024-514695-41-00 - 3. fázisTaking peopleA study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
- Where
- Badalona, Córdoba
- Életkor
- Up to 17 év
- People
- 68 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to join2024-511458-32-00 · EU 2024-511458-32-00 - 2/3. fázisTaking peopleA Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Where
- Badalona, Esplugues de Llobregat, Madrid
- Életkor
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05076175 - 3. fázisTaking peopleA Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
- Where
- Badalona, Córdoba
- Életkor
- 8 év to 18 év
- People
- 80 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to joinNCT06865417 - 3. fázisTaking peopleA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Huelva
- Életkor
- 16 év to 80 év
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07185009 - 3. fázisTaking peopleA Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Where
- Ferrol, Madrid, Sevilla, Valencia
- Életkor
- 2 év to 17 év
- People
- 70 worldwide
- Run by
- Takeda
See details and how to joinNCT06405087 · EU 2023-508804-39-00 - 2. fázisTaking peopleLY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
- Where
- Barcelona, Fuenlabrada, Gijón, Madrid, Santa Cruz de Tenerife
- Életkor
- 18 év and over
- People
- 75 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2025-522338-30-00 · EU 2025-522338-30-00 - 3. fázisTaking peopleA Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Where
- Córdoba, Esplugues de Llobregat, Sabadell, Valencia
- Életkor
- 2 év to 19 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT04844606 - 3. fázisTaking peopleA Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Where
- Ferrol, Madrid, Sevilla, Valencia
- Életkor
- 2 év to 17 év
- People
- 70 worldwide
- Run by
- Takeda
See details and how to joinNCT06100289 · EU 2023-503188-40-00 - 2/3. fázisTaking peopleA phase 2/3, multicenter, randomized, double-blind study to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of oral ozanimod (RPC1063) in pediatric subjects with moderately to severely active ulcerative colitis with an inadequate response to conventional therapy.
- Where
- Badalona, Esplugues De Llobregat, Madrid
- Életkor
- Up to 17 év
- People
- 62 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-509248-86-00 · EU 2023-509248-86-00 - 3. fázisTaking peopleA Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Where
- Barcelona, Madrid, Málaga, Sagunto, Seville
- Életkor
- 2 év to 17 év
- People
- 240 worldwide
- Run by
- Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00 - No phaseTaking peopleImmunological Characteristics of Preclinical IBD
- Where
- Alicante, Badalona, Barcelona, Bilbao, Burgos, Córdoba, Donostia / San Sebastian, Galdakao, Gijón, Madrid, Manresa, Ourense, Oviedo, San Cristóbal de La Laguna, Santiago de Compostela, Terrassa, Valencia, Valladolid, Vigo, Zaragoza
- Életkor
- 18 év and over
- People
- 450
- Run by
- Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
See details and how to joinNCT05698745 - 4. fázisNot yet taking people in SpanyolországImmunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission
- Where
- Badalona, Barcelona, Burgos, Girona, Madrid, Mataro, Motril, Ourense, Sabadell, Santander, Santiago de Compostela, Sevilla, Terrassa, Vigo, Zaragoza
- Életkor
- 60 év and over
- People
- 304
- Run by
- Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
See details and how to joinNCT07248644 · EU 2025-524675-23-00 - No phaseCsak meghívásosEffectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiety and Depression in Ostomy Patients Following Digestive Surgery: A Quasi-Experimental Study.
- Where
- Santiago de Compostela
- Életkor
- 18 év and over
- People
- 70
- Run by
- Hospital Clinico Universitario de Santiago
See details and how to joinNCT07347158